We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$633M
AUM Growth
-$8.48M
Cap. Flow
+$20M
Cap. Flow %
3.16%
Top 10 Hldgs %
94.83%
Holding
21
New
–
Increased
7
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$11.1M
2
TSRO
TESARO, Inc.
TSRO
+$4.5M
3
OPK icon
Opko Health
OPK
+$727K
4
QDEL icon
QuidelOrtho
QDEL
+$248K

Top Sells

Rank Stock Value
1
NXTM
NxStage Medical Inc.
NXTM
+$11M
2
MZOR
Mazor Robotics Ltd.
MZOR
+$8.61M
3
ARAY icon
Accuray
ARAY
+$6.74M
4
EPZM
Epizyme, Inc
EPZM
+$3.39M
5
AMRN
Amarin Corp
AMRN
+$938K

Sector Composition

Rank Sector Weight
1 Healthcare 85.81%
2 Consumer Staples 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$147M 23.26%
1,052,579
+31,104
+3% +$4.5M
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
$129M 20.39%
471,953
– –
MZOR
3
DELISTED
Mazor Robotics Ltd.
MZOR
$85.5M 13.5%
2,471,378
-240,464
-9% -$8.61M
QDEL icon
4
QuidelOrtho
QDEL
$1.21B
$68.6M 10.84%
2,527,554
+10,000
+0.4% +$248K
NXTM
5
DELISTED
NxStage Medical Inc.
NXTM
$57.1M 9.02%
2,276,106
-445,800
-16% -$11M
PACB icon
6
Pacific Biosciences
PACB
$441M
$29.4M 4.65%
8,259,380
+2,752,648
+50% +$11.1M
AMRN
7
Amarin Corp
AMRN
$297M
$25.9M 4.09%
321,218
-15,089
-4% -$938K
OPK icon
8
Opko Health
OPK
$978M
$23.9M 3.78%
3,636,760
+103,760
+3% +$727K
VRML
9
DELISTED
Vermillion, Inc.
VRML
$17M 2.69%
9,241,956
– –
PGEN icon
10
Precigen
PGEN
$2.36B
$16.6M 2.62%
689,002
-5,900
-0.8% -$129K
BIOL
11
DELISTED
Biolase, Inc.
BIOL
$14.2M 2.24%
1,170
– –
AGEN
12
Agenus
AGEN
$326M
$6.25M 0.99%
81,387
-5,706
-7% -$401K
EPZM
13
DELISTED
Epizyme, Inc
EPZM
$4.42M 0.7%
292,380
-224,560
-43% -$3.39M
AXDX
14
CALL
DELISTED
Accelerate Diagnostics
AXDX
$1.97M 0.31%
37,290
+27,290
+273% +$7.4M
BIIB icon
15
Biogen
BIIB
$29.8B
$1.73M 0.27%
6,368
– –
CFRX
16
DELISTED
ContraFect Corporation
CFRX
$1.71M 0.27%
1,478
– –
NXTM
17
CALL
DELISTED
NxStage Medical Inc.
NXTM
$1.47M 0.23%
460,800
+360,800
+361% +$8.93M
TSRO
18
CALL
DELISTED
TESARO, Inc.
TSRO
$814K 0.13%
476,400
+126,400
+36% +$18.3M
AQB icon
19
AquaBounty Technologies
AQB
$4.73M
$98K 0.02%
610
– –
VANI icon
20
Vivani Medical
VANI
$115M
$64K 0.01%
2,117
– –
ARAY icon
21
Accuray
ARAY
$32.2M
– –
-1,418,194
Closed -$6.74M

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Oracle Investment Management held 21 positions worth $633M, down 1.3% from $641M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Oracle Investment Management deployed $20M of net new capital in Q2 2017, adding to 7 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 87% a quarter earlier, followed by Consumer Staples.

On the sell side, the largest reduction was NxStage Medical Inc., an estimated $11M trimmed.

  • Oracle Investment Management added most to Pacific Biosciences in Q2 2017, an estimated $11.1M increase.
  • Oracle Investment Management's biggest Q2 2017 reduction was NxStage Medical Inc., cutting an estimated $11M.
  • Oracle Investment Management fully exited Accuray in Q2 2017, selling an estimated $6.74M.
  • Oracle Investment Management's ten largest holdings make up 95% of its $633M portfolio in Q2 2017.
  • Oracle Investment Management opened 0 new positions and closed 1 in Q2 2017.
  • Oracle Investment Management's portfolio value fell 1.3% quarter-over-quarter to $633M.

Based on Oracle Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.